The global food allergy market is driven by the rising prevalence of food allergies, which has become a significant public health concern worldwide. According to the World Allergy Organization (WAO), approximately 220-250 million people globally suffer from food allergies, with the highest prevalence seen in children under the age of 5. In the United States, studies report that 5-8% of children and 2-3% of adults are affected by food allergies, with peanut and milk allergies being the most common among children. Similarly, in Europe, food allergies impact around 6-8% of children and 3-4% of adults, according to the European Academy of Allergy and Clinical Immunology (EAACI). The increasing number of reported anaphylaxis cases due to severe allergic reactions, especially among children, highlights the growing need for effective diagnosis and treatment solutions in this market. This trend is further exacerbated by environmental factors and changing dietary habits in developing regions.
